Singapore, Nov. 16 -- Indian pharma company Alkem Laboratories has announced the incorporation of a new subsidiary in the Kingdom of Saudi Arabia, to expand the company's business operations and market reach into the Middle East.

The subsidiary, named 'Alkem Pharma Company', will operate as a limited liability company and focus on the manufacture, import, marketing, and distribution of pharmaceuticals and nutraceutical products.

The subsidiary operates as a limited liability company with an authorised capital of SAR 7,500,000, divided into 75,000 shares of SAR 100 each. Alkem Laboratories subscribed to 38,250 shares, amounting to a cash consideration of SAR 3,825,000. This acquisition secures a 51% stake in the total share capital of th...